Pulmonary Tuberculosis
📧 Sign up to get email alerts when something new happens for Pulmonary Tuberculosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-12Clinical Trial Results: Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB [Phase 2]
Phase 2 clinical trial evaluating a 4-month regimen of OPC-167832, Delamanid, and Bedaquiline for safety and efficacy in drug-susceptible pu…
-
CLINICAL_TRIALS trial_result · 2026-08-06Clinical Trial Results: Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) [Phase 2]
Phase 2 trial assessing safety and tolerability of metformin in people with tuberculosis and HIV coinfection has completed with results post…
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment [Phase 2]
Phase 2 trial evaluating rifapentine during the intensive phase of tuberculosis treatment completed; results posted.
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Evaluation of a Rapid Point-of-Care Serological Triage Test for Active TB [NA]
This document reports a completed clinical trial evaluating a rapid point-of-care serological triage test for active pulmonary tuberculosis.
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Bronchoscopic Role in Early Detection of Endobronchial Tuberculosis in Suspected Pulmonary Tuberculosis Patients.
A completed clinical trial from Ain Shams University evaluated the role of bronchoscopy for early detection of endobronchial tuberculosis in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis [Phase 2, Phase 3]
Ongoing Phase 2/Phase 3 clinical trial program evaluating stratified medicine approaches for rifampicin-resistant tuberculosis, including pu…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB) [Phase 2]
A Phase 2 clinical trial evaluating the therapeutic vaccine RUTI for pulmonary tuberculosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: The INSTITUT Study Tuberculosis Nutritional Support
The INSTITUT study evaluating nutritional support in patients with pulmonary tuberculosis and undernutrition has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Diagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary Tuberculosis
A completed clinical trial evaluated the diagnostic accuracy of CAD4TB software and a C-reactive protein assay as triage tests for pulmonary…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort [Phase 3]
This update describes a Phase 3 clinical trial evaluating a shorter, all-oral, precise treatment regimen for rifampicin-resistant tuberculos…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Xpert MTB/RIF Ultra Trial [NA]
This clinical trial update indicates that the Xpert MTB/RIF Ultra diagnostic trial for tuberculosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098 [Phase 2]
Phase 2 trial evaluating Eto (ethambutol) alone and in combination with BVL-GSK098 for rifampicin- and isoniazid-susceptible pulmonary tuber…
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: INSTI's For The Management of HIV-associated TB [Phase 2]
Phase 2 trial evaluating an integrase inhibitor (INSTI)–based regimen for HIV-associated tuberculosis has completed enrollment and posted re…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Breathing Exercise and Tele-Nursing Support for Patients With Tuberculosis: A Single-Group Experimental Study [NA]
A completed, single-group experimental study assessing the impact of breathing exercises and tele-nursing support on quality of life in pati…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Evaluating the Early Bactericidal Activity, Safety and Tolerability of Nebulised RESP301 in Adults With Tuberculosis [Phase 2]
A Phase 2 study evaluating the early bactericidal activity, safety, and tolerability of nebulised RESP301 in adults with rifampicin-suscepti…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Study to Evaluate Safety, Tolerability, and the PK Profile of TBI-223 in Healthy Subjects [Phase 1]
A Phase 1 study evaluating safety, tolerability, and pharmacokinetics of TBI-223 in healthy subjects has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults [Phase 1]
A Phase 1 trial update reports on safety, tolerability, and pharmacokinetics assessment of the TB drug candidate TBAJ-876 in healthy adults,…
-
CLINICAL_TRIALS trial_result · 2025-04-10Clinical Trial Update: Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB [Phase 2]
Phase 2 trial evaluating the safety and efficacy of a 4-month regimen combining OPC-167832, delamanid, and bedaquiline for drug-susceptible …
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Study of TB Lesions Obtained in Therapeutical Surgery
The clinical trial NCT02715271 investigating TB lesions obtained during therapeutical surgery has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Impact of Malnutrition on Pharmacokinetic of Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in TB-HIV Co-infected Children (TB-Speed TB-PK)
A completed clinical trial examines how malnutrition affects the pharmacokinetics of four first-line TB drugs (Rifampicin, Isoniazid, Pyrazi…
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis [Phase 2]
Phase 2 trial evaluating two to four months of combination regimens with DBOS and PBOS for adults with pulmonary tuberculosis; the study has…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Evaluating Newly Approved Drugs for Multidrug-resistant TB [Phase 3]
Phase 3 clinical trials evaluating newly approved drugs for multidrug-resistant tuberculosis have completed, according to a trial update.
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB) [Phase 2]
An exploratory Phase 2 study of bedaquiline (TMC207) in Japanese patients with pulmonary multidrug-resistant tuberculosis has completed. The…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Epidemiologic Study to Assess the IGRA Positivity in Populations With a High TB Burden
Clinical trial update for an epidemiologic study evaluating IGRA positivity in populations with a high tuberculosis burden has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adults [Phase 1]
A Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of the TB drug candidate TBI-223 in healthy adults has completed with …